The U.S. Food and Drug Administration (FDA) plays an important role in ensuring that the therapies patients depend on are safe and effective and that the tests used for patient screening, diagnosis, and monitoring are accurate. In this webinar, LUNGevity’s Dr. Libby Barksdale, Senior Director of Regulatory Affairs and Scientific Policy, and Dr. Tod Guidry, Associate Director of Regulatory and Diagnostics Policy, provide insight on how the FDA regulates oncology products, oversees the conduct of clinical trials, and works with LUNGevity to improve outcomes for patients with lung cancer.

To be notified when events like this webinar are happening, make sure to sign up for LUNGevity Action Network email alerts.